BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/28/2025 2:00:42 PM | Browse: 22 | Download: 104
 |
Received |
|
2025-01-30 06:35 |
|
Peer-Review Started |
|
2025-01-30 06:36 |
|
First Decision by Editorial Office Director |
|
2025-04-08 04:50 |
|
Return for Revision |
|
2025-04-08 04:50 |
|
Revised |
|
2025-05-08 05:16 |
|
Publication Fee Transferred |
|
2025-05-10 16:03 |
|
Second Decision by Editor |
|
2025-08-06 02:36 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-08-06 09:50 |
|
Articles in Press |
|
2025-08-06 09:50 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-11-17 04:03 |
|
Publish the Manuscript Online |
|
2025-11-28 14:00 |
| ISSN |
2220-3141(online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Critical Care Medicine |
| Manuscript Type |
Retrospective Study |
| Article Title |
Retrospective evaluation of efficacy of CytoSorb® therapy in septic shock patients in a tertiary care intensive care unit
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Mayur S Shah, Vedika V Sharma, Syed J Patel and Abdul S Ansari |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Abdul S Ansari, Critical Care Medicine, Nanavati Max Super Specialty Hospital, Swami Vivekananda Road, Vile Parle (West), Mumbai 400056, Mahārāshtra, India. drabdulansari@gmail.com |
| Key Words |
CytoSorb® therapy; Cytokine hemoadsorption; Septic shock; Acute physiology and chronic health evaluation scores; Sepsis associated organ failure scores; Mean arterial pressure; Mechanical ventilation |
| Core Tip |
CytoSorb® is an innovative extracorporeal cytokine hemoadsorption device designed to stabilize hemodynamic parameters and regulate the cytokine storm in sepsis. This retrospective study evaluated the efficacy of CytoSorb® hemoadsorption therapy as an adjunct to standard care in intensive care unit patients with septic shock. The findings indicate significant reductions in inflammatory biomarkers, vasopressor requirements, along with improvements in organ recovery and survival outcomes. Additionally, no major adverse events were reported in patients receiving the therapy. The study underscores CytoSorb® ability to modulate hyperinflammation from cytokine storms and stabilize hemodynamics, thus facilitating early shock reversal, and improving clinical outcomes in critically ill patients. |
| Publish Date |
2025-11-28 14:00 |
| Citation |
Shah MS, Sharma VV, Patel SJ, Ansari AS. Retrospective evaluation of efficacy of CytoSorb® therapy in septic shock patients in a tertiary care intensive care unit. World J Crit Care Med 2025; 14(4): 105600 |
| URL |
https://www.wjgnet.com/2220-3141/full/v14/i4/105600.htm |
| DOI |
https://dx.doi.org/10.5492/wjccm.v14.i4.105600 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
